Search Results - "Chipoya, Terence"

Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial by Jacobs, Tom G, Mumbiro, Vivian, Cassia, Uneisse, Zimba, Kevin, Nalwanga, Damalie, Ballesteros, Alvaro, Domínguez-Rodríguez, Sara, Tagarro, Alfredo, Madrid, Lola, Mutata, Constantine, Chitsamatanga, Moses, Bwakura-Dangarembizi, Mutsa, Passanduca, Alfeu, Buck, W Chris, Nduna, Bwendo, Chabala, Chishala, Najjingo, Elizabeth, Musiime, Victor, Moraleda, Cinta, Colbers, Angela, Mujuru, Hilda A, Rojo, Pablo, Burger, David M

“…Abstract Background We evaluated dolutegravir pharmacokinetics in infants with human immunodeficiency virus (HIV) receiving dolutegravir twice daily (BID) with…”
Get full text

Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE Trial by Chabala, Chishala, Wobudeya, Eric, van der Zalm, Marieke M, Kapasa, Monica, Raichur, Priyanka, Mboizi, Robert, Palmer, Megan, Kinikar, Aarti, Hissar, Syed, Mulenga, Veronica, Mave, Vidya, Musoke, Philippa, Hesseling, Anneke C, McIlleron, Helen, Gibb, Diana, Crook, Angela, Turkova, Anna, Choo, Louise, Wills, Genevieve, Thomason, Margaret J, Teera, Jaqueline, Owen-Powell, Ellen, LeBeau, Kristen, Baptiste, David, McGowan, Charlotte, Spyer, Moira, Lungu, Joyce, Zimba, Kevin, Zyambo, Khozya, Chungu, Chalilwe, Tembo, Chimuka, Kunda, Sharon, Shingalili, Ellen, Zulu, Semy, Chipoya, Terence, Mwanakalanga, Habulembe, Chambela, Elias, Hankombo, Jessy M, Kalumbi, Mox Malama, Chola, Daniel, Malama, Stephen, Nansamba, Winnie, Ssenyonga, Mark, Ssengooba, Willy, Businge, Gerald, Workman, Jessica, Demers, Anne-Marie, Schaaf, Simon, Gie, Robert, Walters, Elisabetta, Zimri, Warren, Hoddinott, Graeme, van Deventer, Anneen, Goussard, Pierre, Morrison, Julie, Nijampurkar, Aparna, Khan, Sameer, Joseph, Bency, Bhavani, Perumal Kannabiran, Prathiksha, G, Baskaran, Dhanaraj, Gomathi, N S, Mythily, V, Kumar, Hemanth, Chelvi, Silambu, Sekar, L, Hanna, Luke, Ramesh, K, Latha, Hema, Bharathi, S, Banu, Parveen, Xavier, Dino, Kumar, Manjith, Guru, K, Kumar, Sasi, Kesavan, A, Gunasundari, A, Mangalambal, G, Nagarajan, Valarmathi, Shankar, Shakeela, Selvi, R, Vaishnavi, S, Yadav, Krishna, Supriya, R, Giranab, Hema, Seetha, A, Mary, Stella, Gopika, S, Rohini, S, Revathy, M, Balaji, Sarath, Elilarasi, S, Ganesh, J, Aravind, M A, Mulambo, Sylvia, Mwanyungwi, Hope, Tapse, Dharati, Sane, Manasi, Abdullah, Amina, Nakalanzi, Sarah

“…Abstract Background Children with human immunodeficiency virus (HIV, CWH) are at high risk of tuberculosis (TB) and face poor outcomes, despite antiretroviral…”
Get full text

Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV by Chabala, Chishala, Turkova, Anna, Kapasa, Monica, LeBeau, Kristen, Tembo, Chimuka H., Zimba, Kevin, Weisner, Lubbe, Zyambo, Khozya, Choo, Louise, Chungu, Chalilwe, Lungu, Joyce, Mulenga, Veronica, Crook, Angela, Gibb, Diana, McIlleron, Helen

“…Lopinavir/ritonavir plasma concentrations are profoundly reduced when co-administered with rifampicin. Super-boosting of lopinavir/ritonavir is limited by…”
Get full text

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial by Mulenga, Veronica, MSc, Musiime, Victor, PhD, Kekitiinwa, Adeodata, MMed, Cook, Adrian D, MSc, Abongomera, George, MSc, Kenny, Julia, BMBCh, Chabala, Chisala, MMed, Mirembe, Grace, MMed, Asiimwe, Alice, MSc, Owen-Powell, Ellen, MRes, Burger, David, Prof, McIlleron, Helen, PhD, Klein, Nigel, Prof, Chintu, Chifumbe, Prof, Thomason, Margaret J, PhD, Kityo, Cissy, MSc, Walker, A Sarah, Prof, Gibb, Diana M, Prof

“…Summary Background WHO 2013 guidelines recommend universal treatment for HIV-infected children younger than 5 years. No paediatric trials have compared…”
Get full text

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV by Fitzgerald, Felicity C, Lhomme, Edouard, Harris, Kathryn, Kenny, Julia, Doyle, Ronan, Kityo, Cissy, Shaw, Liam P, Abongomera, George, Musiime, Victor, Cook, Adrian, Brown, Julianne R, Brooks, Anthony, Owen-Powell, Ellen, Gibb, Diana M, Prendergast, Andrew J, Sarah Walker, A, Thiebaut, Rodolphe, Klein, Nigel

“…Abstract Objective Immune activation is associated with morbidity and mortality during human immunodeficiency virus (HIV) infection, despite receipt of…”
Get full text

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia by Chabala, Chishala, Jacobs, Tom G, Moraleda, Cinta, Ndaferankhande, John M, Mumbiro, Vivian, Passanduca, Alfeu, Namuziya, Natasha, Nalwanga, Damalie, Musiime, Victor, Ballesteros, Alvaro, Domínguez-Rodríguez, Sara, Chitsamatanga, Moses, Cassia, Uneisse, Nduna, Bwendo, Bramugy, Justina, Sacarlal, Jahit, Madrid, Lola, Nathoo, Kusum J, Colbers, Angela, Burger, David M, Mulenga, Veronica, Buck, W Chris, Mujuru, Hilda A, te Brake, Lindsey H M, Rojo, Pablo, Tagarro, Alfredo, Aarnoutse, Rob E

“…Abstract Optimal antituberculosis therapy is essential for favorable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in…”
Get full text